Table 1.
Clinical indicators at various time points during treatment.
| Clinical indicators | ACS patients (n = 38) | p-value | ||
|---|---|---|---|---|
| ACS-pre | ACS-post1 | ACS-post2 | ||
| TG (0–1.7 mmol/L) | 1.68 ± 0.91 | 1.37 ± 0.89 | 1.37 ± 0.65 | 0.2169 |
| Chol (0–5.18 mmol/L) | 5.09 ± 1.08 | 3.85 ± 1.18 | 3.60 ± 1.03 | 6.341 × 10−5 |
| HDL (1.29–1.55 mmol/L) | 1.09 ± 0.26 | 1.08 ± 0.26 | 1.08 ± 0.26 | 0.991 |
| LDL (0–3.37 mmol/L) | 3.32 ± 0.87 | 2.17 ± 0.80 | 1.90 ± 0.80 | 3.575 × 10−6 |
Values are presented as mean ± SD. All p-values are from the t-test.
M, male; F, female; TG, triglycerides; Chol, cholesterol; HDL, high-density lipoprotein; LDL, low-density lipoprotein; ALB, albumin; Cr, Creatinine; cTnT, cardiac troponin T; BNP, B-type natriuretic peptides; EF, ejection fraction; HbA1c, hemoglobin A1c.
The normal value range of the indicator is in brackets (*p < 0.05, **p < 0.01, and ***p < 0.001).